Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Creatine Kinase MB Monoclonal Antibody (04)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA530292
Description
This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%). This antibody has specificity for Human CKM/CK-MM.
The protein encoded by this gene is a cytoplasmic enzyme involved in energy homeostasis. The encoded protein reversibly catalyzes the transfer of phosphate between ATP and various phosphogens such as creatine phosphate. It acts as a homodimer in brain as well as in other tissues, and as a heterodimer with a similar muscle isozyme in heart. The encoded protein is a member of the ATP:guanido phosphotransferase protein family. A pseudogene of this gene has been characterized.
Specifications
Creatine Kinase MB | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative | |
P06732, P12277 | |
Ckb, CKM | |
Recombinant Human CKM/CK-MM Protein. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA | |
04 | |
Unconjugated | |
Ckb | |
Bck; B-CK; Brain creatine kinase; CK MB; Ck3; Ck-3; CKB; Ckbb; Ckbr; Ckm; CKMM; CPK-B; CPK-M; creatine kinase B; creatine kinase B chain; creatine kinase brain; creatine kinase brain-type; Creatine kinase B-type; creatine kinase M chain; Creatine kinase M-type; creatine kinase, brain; creatine kinase, M-type; creatine kinase, muscle; creatine kinase-B; creatine kinase-M; Creatine phosphokinase B-type; Creatine phosphokinase M-type; epididymis luminal protein 211; epididymis secretory protein Li 29; HEL-211; HEL-S-29; MCK; M-CK | |
Mouse | |
Protein A | |
RUO | |
1152, 1158 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction